Introduction: Gonadotropin-releasing hormone (GnRH) agonist triggers are increasingly used in antagonist vitro fertilization (IVF) cycles to prevent ovarian hyperstimulation syndrome (OHSS) following a robust response. The luteolytic effects of GnRH agonists inhibit implantation or spontaneous pregnancy, warranting freezing available blastocysts for future transfer after the risk OHSS subsides....

In the twentieth century, a whole teaching of mastopathy was formed. However, over time, accumulated data have questioned existence as separate nosological form, because term “fibrocystic disease” while mastalgia is most common symptom does not correspond to holistic concept disease. This “disease” can be diagnosed in any woman and more or less successfully treated. United States, this obsolete...

Data collected from medical literature indicate that dopaminergic agonists alleviate Restless Legs Syndrome symptoms while dopaminergic agonists antagonists aggravate them. Dopaminergic agonists is a physiological regulator of thyroid-stimulating hormone. Dopaminergic agonists infusion diminishes the levels of thyroid hormones, which have the ability to provoke restlessness, hyperkinetic states...

In in vitro fertilization (IVF) cycles controlled ovarian hyperstimulation (COH) is established by gonadotropins in combination with gonadotropin-releasing hormone (GnRH) agonists or antagonists, to prevent premature luteinizing hormone (LH) surge. The aim of our study was to improve the understanding of gene expression profile of cumulus cells (CC) in terms of ovarian stimulation protocol and ...

intervene therapeutically with children exposed to disasters affecting the adults in their world. New prospects for luteinising hormone releasing hormone as a contraceptive and therapeutic agent Gonadal function is controlled by luteinising hormone (LH) and follicle-stimulating hormone (FSH) from the pituitary gland. Since the release of these hormones depends on secretion of hypothalamic lutei...